| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |